Vestmark Advisory Solutions Inc. Grows Stock Holdings in UnitedHealth Group Incorporated $UNH

Vestmark Advisory Solutions Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 14,103 shares of the healthcare conglomerate’s stock after purchasing an additional 1,942 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in UnitedHealth Group were worth $4,400,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Nuveen LLC acquired a new stake in UnitedHealth Group during the first quarter worth about $3,846,764,000. Vanguard Group Inc. boosted its stake in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP grew its stake in UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. National Bank of Canada FI increased its stake in shares of UnitedHealth Group by 137.8% in the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock worth $859,518,000 after buying an additional 950,928 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after purchasing an additional 847,054 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.8%

Shares of UNH stock opened at $324.29 on Friday. The firm has a market capitalization of $293.75 billion, a PE ratio of 16.93, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a fifty day moving average of $345.84 and a two-hundred day moving average of $322.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $7.15 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Wall Street Analysts Forecast Growth

UNH has been the subject of several recent research reports. Piper Sandler lowered their target price on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. Royal Bank Of Canada increased their price objective on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Leerink Partners set a $410.00 price target on UnitedHealth Group and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. KeyCorp upped their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company boosted their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Eighteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.